For any further information
In-vitro analysis of Quantum Molecular Resonance effects on human mesenchymal stromal cells.
S. Sella, V. Adami, E. Amati, M. Bernardi, K. Chieregato, P. Gatto P, et al. PLoS ONE 2018 13 (1): e0190082.
Biophysical effects of high frequency electrical field (4-64 MHz)
on muscle fibers in culture
Dal Maschio M, Canato M, Pigozzo FM, et al. Biophysical effects of high frequency electrical field (4–64 MHz) on muscle fibers in culture. Basic Applied Myology 2009; 19:49–56.
Favorable Tissue Effects of Quantum Molecular Resonance Device (Vesalius®) Compared with Standard Electrocautery
Schiavon M, Calabrese F, Nicotra S, et al. Favorable tissue effects of quantum molecular resonance device (VESALIUS®) compared with standard electrocautery: a novel paradigm in lung surgery. Eur Surg Res 2007; 39:222–8.
Quantum molecular resonance technology in hard-to-heal extremity wounds: histological and clinical results.
M. Fraccalvieri, M. Salomone, C. Di Santo, E. Ruka U. Morozzo, S. Bruschi S. Int Wound J 2017; 14:1313–1322.
Electrical signaling in control of ocular cell behaviors
Zhao M, Chalmers L, Cao L, Viera AC, Mannis M, Reid B. Electrical signaling in control of ocular cell behaviors. Prog Retin Eye Res 2012; 31(1):65–88.
Wound healing in rat cornea: the role of electric currents
Reid B, Song B, McCaig CD, Zhao M. Wound healing in rat cornea: the role of electric currents. FASEB J. 2005; 19(3):379–386.
Transcutaneous periorbital electrical stimulation in the treatment of dry eye.
E. Pedrotti, F. Bosello, A. Fasolo, A.C. Frigo, I. Marchesoni, A. Ruggeri, G. Marchini. Br J Ophthalmol 2017, 101:814-9.
Innovative radiofrequency electrotherapy significantly reduces cornea perforation in an alkali burn murine model
A. Ruggeri, T. Dyrdin, M. Barbariga, P. Rama, G. Ferrari. Proc. ARVO 2018 Annual Meeting, 2018.
High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction
G. Ferrari, A. Colucci, M. Barbariga, A. Ruggeri, P. Rama. Cornea: July 23, 2019
Mixed dry eye patients successfully treated by the innovative high-frequency electrotherapy device Rexon-Eye®
A.Ruggeri, E.Fatigati, L.Vigo. ARVO 2020 Annual Meeting, June 2020
Improvement in mixed-type dry eye patients after treatment with the QMR®-based electrotherapy device Rexon-Eye®
A. Ruggeri , A.Trivli , G. Dalianis , C. Terzidou. ARVO 2021 Annual Meeting, May 2021
Il dispositivo medico Rexon-Eye e la sua innovativa tecnologia QMR sono stati presentati sullo...
In its April 2020 issue "New Zealand Optics" offers its readers an interesting highlighting about...
A remarkable interest was raised by the editorial published a few days ago in the Giornale di...